Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Cardiology|April 18, 2002
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alphaWolfram Doehner, Mathias Rauchhaus, Ian F Godsland, et al.
American Heart Journal|August 11, 2012
Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarctionMichael D Miedema, Jay N Cohn, Ross F Garberich, et al.
Journal of Cardiac Failure|May 10, 2005
Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure TrialGiuseppina Majani, Anna Giardini, Cristina Opasich, et al.
European Journal of Preventive Cardiology|September 22, 2021
Early cardiovascular structural and functional abnormalities as a guide to future morbid eventsDaniel A Duprez, Sue Duval, Lynn Hoke, et al.
American Journal of Hypertension|April 3, 2003
Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular eventsElizabeth Grey, Chris Bratteli, Stephen P Glasser, et al.
Journal of the American Society of Hypertension : JASH|April 23, 2010
Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertensionMasood Gilani, Daniel R Kaiser, Christopher W Bratteli, et al.
Journal of the American College of Cardiology|September 13, 2008
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)Serge Masson, Roberto Latini, Inder S Anand, et al.
Journal of the American Society of Hypertension : JASH|July 2, 2011
Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observationsDaniel A Duprez, Natalia Florea, Wei Zhong, et al.
Pageof 14